Brind.
  1. South Africa is a key market in Africa, where German companies are currently operating.

Aspen Pharmacare gained rights to manufacture medicines with Merck/MSD to improve access to pharmaceuticals in Africa.

2 reports, 2 independent Updated Jul 26
Gone quiet
Reports
2
Developments
4
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Aspen Pharmacare gained rights to manufacture medicines with Merck/MSD to improve access to pharmaceuticals in Africa.

Who's involved

What this event is mainly about
South AfricaAspen PharmacareMerck KGaA

How it developed

Newest first. Tap a step to see who reported it.
  1. Adcock Ingram and Aspen Pharmacare are contributing to the establishment of a regional medical hub in sub-Saharan Africa.Sub-event
  2. Aspen Pharmacare was licensed to manufacture medicines in South Africa as of August 1, 2026.Sub-event
  3. Aspen Pharmacare is a key African supplier, and generic manufacturing is based in India.1 source
  4. SA company Aspen secured manufacturing rights from Merck/MSD for African medicine access.1 source

Keep exploring

Part of

South Africa is a key market in Africa, where German companies are currently operating.

Also in this story

All 4 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • businessday.co.zaAspen positions itself as key African supplier of Merck HIV pill
  • news24.comAspen secures right to manufacture revolutionary HIV prevention drug once approved | News24